#Type 2 Diabetes

Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies

Dia Beta Labs secured €1.4 million in funding from undisclosed investors. This investment will advance its development of next-generation therapies for obesity and Type 2 diabetes. The company's technology focuses on protecting and repairing insulin-producing beta-cells.

Therapeutic inertia: An age old problem with a 21st century solution